Skip to main content
. 2010 Apr 5;28(14):2467–2474. doi: 10.1200/JCO.2009.26.6213

Table A2.

Information About 100 Top Ranking Glioma Susceptibility SNPs From Our Previous Glioma GWAS

SNP Chr Gene Base Change MAF
Log-Rank P χ2 Test P
NCBI MDACC Cases Codominant Dominant Recessive
rs13099725 3 C3orf56 A/G 0.15 0.15 .002 .043 .35 .032
rs4734443 8 RGS22 C/T 0.458 0.38 .003 .067 .87 .033
rs7325927 13 LIG4 C/T 0.225 0.29 .008 .027 .004 .052
rs11670188 19 BTBD2 A/G 0.217 0.23 .009 .036 .02 .25
rs2297440 20 RTEL1 C/T 0.258 0.18 .02 .038 .024 .083
rs6010620 20 RTEL1 A/G 0.258 0.19 .021 .051 .041 .17
rs1380994 8 RGS22 A/G 0.467 0.39 .038 .077 1 .033
rs9656979 8 CCDC26 C/T 0.407 0.45 .0381 .05 .23 .12
rs10131032 14 AKAP6 A/G 0.108 0.08 .0435 .13 .14 .079
rs2781321 1 DAB1 A/G 0.458 0.47 .0632 .57 .31 .91
rs10924559 1 SMYD3 A/G 0.044 0.16 .0671 .64 .56 .53
rs2094354 13 LOC644623 A/G 0.125 0.07 .069 .41 .8 .21
rs1509937 10 CTNNA3 A/G 0.383 0.36 .1006 .073 .49 .065
rs2110922 2 SLC8A1 G/T 0.392 0.39 .1028 .09 .091 .03
rs9514044 13 C13orf39 C/T 0.175 0.27 .113 .27 .16 .24
rs10464870 8 CCDC26 C/T 0.175 0.23 .1137 .018 .011 .017
rs6765837 3 VPS8 C/T 0.467 0.46 .121 .046 .025 .79
rs17745484 2 DNMT3A C/T 0.325 0.36 .1422 .12 .076 .61
rs1563834 12 HMGA2 A/G 0.102 0.14 .1462 .056 .045 .027
rs3770876 2 CRIM1 A/C 0.353 0.45 .1662 .045 .041 .054
rs200888 20 PTPNS1 G/T 0.417 0.41 .1785 .4 .22 .36
rs13268364 8 PEBP4 C/T 0.267 0.28 .1876 .019 .13 .052
rs1681655 3 TBL1XR1 C/T 0.133 0.09 .1922 .015 .22 .31
rs171125 16 TP53TG3 A/G 0.147 0.11 .2603 .26 .24 .21
rs7513553 1 PPT1 G/T 0.186 0.21 .2626 .2 .075 .49
rs7282227 21 C21orf37 C/T 0.075 0.07 .2658 .19 .14 .38
rs7849795 9 C9orf123 G/T 0.259 0.2 .3161 .17 .56 .06
rs1340949 10 LOC220929 C/T 0.475 0.42 .3192 .28 .54 .24
rs9922943 16 SLC38A8 C/T 0.15 0.2 .3271 .5 .62 .24
rs891835 8 CCDC26 G/T 0.175 0.24 .3308 .011 .024 .013
rs10229692 7 CNTNAP2 A/G 0.059 0.09 .3327 .46 .62 .22
rs10149208 14 LOC729646 A/G 0.435 0.38 .335 .73 .45 1
rs6931798 6 LRFN2 C/T 0.138 0.22 .3541 .76 .47 .75
rs12033655 1 DAB1 C/T 0.375 0.27 .3578 .49 .83 .24
rs13023983 2 FIGN A/C 0.142 0.24 .3706 .94 .79 .78
rs999051 1 PRELP C/T 0.169 0.12 .3752 .5 .24 .72
rs2206920 20 BMP2 A/G 0.085 0.1 .3777 .35 .17 .96
rs7124728 11 LOC220070 C/T 0.362 0.36 .3818 .52 .93 .27
rs17748 11 TREH C/T 0.233 0.23 .3869 .63 .39 .53
rs9369226 6 LRFN2 A/G 0.161 0.23 .388 .81 .53 .75
rs4980684 11 FGF19 C/T 0.408 0.41 .4464 .79 .7 .51
rs1941114 18 CHST9 A/G 0.158 0.13 .4598 .24 .44 .2
rs2853676 5 TERT A/G 0.275 0.33 .474 .11 .063 .15
rs6914611 6 PREP C/T 0.1 0.08 .4856 .36 .32 .19
rs6869535 5 PTGER4 A/G 0.142 0.13 .5073 .65 .64 .37
rs8127220 21 C21orf37 A/G 0.067 0.06 .5249 .36 .32 .38
rs7562790 2 CRIM1 G/T 0.358 0.45 .542 .043 .042 .061
rs7219550 17 POLR2A A/G 0.149 0.18 .561 .35 .2 .78
rs7257116 19 MKNK2 C/T 0.317 0.35 .5779 .68 .38 .7
rs4490127 2 COL6A3 G/T 0.5 0.45 .5914 .079 .028 .81
rs10771012 12 SOX5 A/G 0.475 0.47 .5922 1 .99 .97
rs1789374 11 RDX C/T 0.263 0.33 .5969 .96 .83 .8
rs11727564 4 ANP32C G/T 0.308 0.29 .6089 .28 .29 .15
rs2224601 9 C9orf123 A/G 0.237 0.19 .614 .57 .68 .3
rs2208742 9 C9orf123 C/T 0.242 0.19 .614 .57 .68 .3
rs10197919 2 FBLN7 A/G 0.441 0.44 .6147 .74 .51 .91
rs1063192 9 CDKN2A/B C/T 0.4 0.49 .6193 .73 .47 .57
rs727675 14 HECTD1 A/G 0.475 0.46 .6268 .91 .7 .95
rs4977756 9 CDKN2A/B A/G 0.342 0.46 .6423 .49 .3 .35
rs6042018 20 FKBP1A C/T 0.425 0.32 .6454 .61 .91 .33
rs4837334 9 SH3GLB2 A/G 0.317 0.3 .6527 .59 .74 .41
rs6761 17 POLR2A C/T 0.392 0.4 .6562 .83 .99 .56
rs2180273 1 TRIM67 C/T 0.178 0.2 .669 .43 .56 .22
rs833141 2 PDE1A G/T 0.108 0.11 .675 .45 .71 .21
rs3853894 17 ZBTB4 A/G 0.5 0.16 .694 .55 .28 .64
rs1384847 4 RASL11B A/G 0.067 0.06 .6975 .71 .76 .41
rs1079950 6 PARK2 A/G 0.277 0.37 .7238 .49 .29 .41
rs7594432 2 DNMT3A C/T 0.383 0.39 .7306 .76 .55 .55
rs11682175 2 VRK2 C/T 0.425 0.43 .7381 .89 .68 .71
rs870283 1 CAMTA1 C/T 0.442 0.35 .75 .7 .78 .39
rs3748699 1 UCK2 A/G 0.133 0.12 .755 .088 .12 .075
rs16852868 1 UCK2 A/C 0.129 0.12 .758 .088 .12 .075
rs10082804 12 FLJ23560 C/T 0.085 0.16 .7625 .32 .22 .53
rs10488631 7 TNPO3 C/T 0.167 0.11 .7687 .95 .76 .97
rs12531711 7 TNPO3 A/G 0.167 0.11 .7687 .95 .76 .97
rs7862315 9 USP20 A/G 0.088 0.13 .7837 .78 .5 .96
rs9901643 17 POLR2A A/G 0.15 0.16 .7938 .58 .48 .61
rs1998027 1 TRIM67 A/G 0.32 0.46 .7943 .36 .18 .97
rs10170021 2 BBS5 C/T 0.217 0.31 .7967 .57 .55 .3
rs498872 11 PHLDB1 C/T 0.325 0.33 .8101 .79 .96 .52
rs1484874 18 SLC14A2 A/G 0.392 0.44 .8147 .95 .91 .79
rs2157719 9 CDKN2A/B A/G 0.383 0.48 .8165 .54 .28 .92
rs16904140 8 CCDC26 A/G 0.158 0.23 .8389 .37 .35 .2
rs6662747 1 CAMTA1 A/G 0.48 0.42 .8448 .84 .97 .57
rs11887120 2 DNMT3A C/T 0.356 0.37 .8568 .57 .88 .3
rs9526689 13 DLEU7 A/G 0.058 0.05 .8623 .7 .85 .50
rs4295627 8 CCDC26 G/T 0.142 0.2 .8643 .49 .28 .45
rs2678919 2 VRK2 A/G 0.258 0.25 .865 .64 .68 .46
rs7325443 13 LIG4 C/T 0.17 0.22 .9011 .27 .33 .3
rs265120 1 GPATCH2 C/T 0.102 0.15 .9162 .82 .57 .72
rs4738442 8 JPH1 C/T 0.075 0.03 .9236 .69 .67 .49
rs7300686 12 TMEM132C C/T 0.457 0.41 .9255 .41 .77 .19
rs9959776 18 LOC728662 G/T 0.358 0.45 .9295 .98 .93 .91
rs6470745 8 CCDC26 A/G 0.142 0.22 .9459 .8 .55 .92
rs2243988 21 RUNX1 C/T 0.331 0.38 .9521 .75 .56 .8
rs1412829 9 CDKN2A/B C/T 0.367 0.47 .9671 .68 .44 .92
rs6092361 20 TFAP2C C/G 0.191 0.38 .9793 .93 .8 .71
rs2736100 5 TERT G/T 0.45 0.41 .9916 .85 .58 .8
rs927704 14 HECTD1 A/C 0.425 0.44 .9958 .96 .87 .86
rs2072532 2 SLC8A1 C/T 0.458 0.43 .1120 .058 .022 .15

Abbreviations: SNP, single nucleotide polymorphism; GWAS, genome-wide association study; Chr, chromosome; MAF, minor allele frequency; NCBI, National Center for Biotechnology Information; MDACC, M. D. Anderson Cancer Center.

*

MAF for CEU in the NCBI dbSNPs database.

Log-rank test P value for overall survival.

P value for difference in genotype distributions between long-term survivors and short-term survivors.